Piclidenoson is a First-in-class, Orally Active A3AR Agonist for Cancer and Inflammation Research
Adenosine receptors (ARs) comprise a group of G protein-coupled receptors (GPCR) which mediate the physiological actions of adenosine. To date, there are four known types of adenosine receptors in humans:…